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Regulatory T cells (Tregs) play a crucial role in con-
trolling autoimmune and inflammatory responses.
Recent studies have demonstrated that dendritic
cells (DCs) contribute to the homeostasis of periph-
eral Tregs. Autophagy, a critical pathway for cellular
homeostasis, is active in DCs and is upregulated in
different inflammatory conditions. We have shown
that Tregs are expanded and have phenotypic alter-
ations and impaired suppressive functions in mice
with autophagy-deficient DCs. RNA profiling of Tregs
revealed that autophagy in DCs is required to stabi-
lize Treg expression signatures. This phenotype is
linked to the downregulation of ICOS-Ligand expres-
sion in autophagy-deficient DCs, a consequence of
the accumulation of ADAM10, the metalloproteinase
responsible for its cleavage. Upon inflammation, in
antigen-induced arthritis, mice with autophagy-defi-
cient DCs exhibit increased synovial inflammation
and cartilage and bone erosion correlating with
Treg-to-Th17 conversion. Our data reveal a mecha-
nism that couples autophagy deficiency in DCs to
the function, homeostasis, and stability of Tregs.
INTRODUCTION
Regulatory T cells (Tregs) play a crucial role in controlling autoim-
mune and inflammatory responses (Josefowicz et al., 2012; Kim
et al., 2007). Themolecular signature of Tregs is characterized by
the expression of the forkhead box transcription factor (Foxp3),
which is essential to their maintenance and function (Fontenot
et al., 2003). A stable expression of Foxp3 in Tregs is therefore
crucial for ensuring Treg function, limiting autoimmunity, and
maintaining self-tolerance. Indeed, several reports have chal-
lenged the stability of Tregs and demonstrated their conversion
toward Th1/Th17 and, more recently, toward Th2 cells. In this
context, Tregs downregulate the expression of Foxp3. These ob-This is an open access article under the CC BY-Nservations were facilitated by the use of fate-mapping Tregs,
which allowed us to unambiguously demonstrate the plasticity
of these cells in vivo. Initial studies have shown that Tregs could
become unstable in a lymphopenic environment and lose the
expression of Foxp3 (Duarte et al., 2009; Komatsu et al., 2009).
These findings were controversial, as they could solely account
for a deprivation in interleukine-2 (IL-2) that is necessary to sus-
tain Tregs’ stability. Later studies, however, have demonstrated
the Th1/Th17 conversion of Tregs using fate-reporter cells in
mouse models of three autoimmune diseases: experimental
autoimmune encephalomyelitis (Bailey-Bucktrout et al., 2013),
type 1 diabetes (Zhou et al., 2009), and collagen-induced arthritis
(Komatsu et al., 2014). In parallel, upon exposure to inflammatory
stimuli in vitro, Tregs can lose Foxp3 expression and differentiate
into effector Th17, Th1, or Th2 cells (Hoffmann et al., 2009; Xu
et al., 2007). These findings were also recapitulated in human
Tregs, which lose Foxp3 expression upon T cell receptor (TCR)
stimulation in the presence of pro-inflammatory cytokines (Koe-
nen et al., 2008). In addition, unstable Tregs were detected in
several autoimmune diseases, such as type 1 diabetes (Long
et al., 2010), systemic lupus erythematosus (Valencia et al.,
2006), and psoriasis (Bovenschen et al., 2011).
Therefore, understanding which factors can control the
stability and plasticity of Tregs is crucial in the context of autoim-
munity. Several studies have focused on identifying such
intrinsic factors. Among them, epigenetically marked cis-ele-
ments, such as the conserved noncoding sequence 2 (CNS2)
of the Foxp3 gene (Feng et al., 2014), are essential for Treg sta-
bility. Other intrinsic important factors such as TCR signaling
(Levine et al., 2014), Neuropilin-1 expression (Overacre-Delgoffe
et al., 2017), or IL-2 receptor signaling (Chinen et al., 2016) were
also demonstrated to be crucial for maintaining Treg identity.
While the majority of these studies have focused on identifying
intrinsic factors that control Treg function and stability, limited
work has focused on identifying such extrinsic factors. In that
aspect, different groups have reported a direct role of antigen-
presenting cells (APCs) on the homeostasis of natural or anti-
gen-induced Tregs. Indeed, Tregs were shown to interact with
both conventional and plasmacytoid dendritic cells (DCs) (Dar-
rasse-Je`ze et al., 2009; Ito et al., 2007) in the context ofCell Reports 28, 21–29, July 2, 2019 ª 2019 The Author(s). 21
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
autoimmunity or tumors. In both instances, these interactions
were beneficial for the function and maintenance of Tregs.
We were interested in the role of DCs in controlling Treg
compartments. We focused more precisely on the potential
role of the macroautophagy pathway (hereafter referred as
autophagy) in DCs on Tregs’ phenotypes and functions. The
autophagy pathway has been critically involved in APCs to con-
trol aspects of both innate and adaptive immune responses
in various contexts of inflammation or pathogen infections
(Deretic et al., 2013). Indeed, targeted deletion of autophagy
in DCs has been shown to modulate CD4 and CD8 T cell re-
sponses in different infectious models. However, few studies
have described a contribution of the pathway in APCs to periph-
eral tolerance.
Here, we show that autophagy in DCs is required for Treg ho-
meostasis and function both in steady state and upon inflamma-
tion. This phenotype is linked to a decreased expression of
ICOS-Ligand (ICOS-L) in autophagy-deficient DCs, a co-stimu-
latory molecule that is crucial for Tregs’ maintenance and
effector function (Burmeister et al., 2008; Redpath et al., 2013).
As a consequence, in the absence of autophagy in DCs, Tregs
are dysfunctional and unstable, leading to disease exacerbation
in a mouse model of rheumatoid arthritis (RA). Our study iden-
tifies a mechanism by which autophagy in DCs contributes to
the maintenance of peripheral T cell tolerance.
RESULTS AND DISCUSSION
Tregs from Atg5/ DCMice Are Expanded and Show an
Activated and Effector Phenotype
We analyzed, in the steady state, the Treg compartment in mice
with autophagy-deficient DCs (Atg5/ DCmice). We found that
compared to their littermate controls, Atg5/ DC mice had
increased frequencies and absolute numbers of total Tregs in
their secondary lymphoid organs (SLOs) (Figures 1A, S1A, and
S1B). This observation correlates with increased peripheral
proliferation of Tregs in Atg5/ DC mice (Figures 1B and 1C).
Interestingly, the frequency of Neuropilin-1+ Tregs was also
increased in the periphery (Figure S1C), suggesting that this
phenotype was related to natural Tregs’ proliferation. We then
analyzed if a particular subset of Tregs was expanded in
Atg5/ DC mice. We found an increase in the percentage and
absolute numbers of CD25Low and CD25Neg Treg subsets in
SLO, while the absolute counts of CD25High Tregs remained un-
changed (Figures 1D, 1E, and S1D).
All these changes did not affect thymic Tregs since the
frequency, proliferation, and CD25 subsets of Tregs remained
unchanged in the thymus of Atg5/ DC mice (Figures S1E
and S1F).
We next analyzed the phenotype of Tregs in Atg5/ DC mice
and their littermate controls. We found thatAtg5/DCmice had
a significantly increased frequency of effector Tregs in the steady
state (CD44High CD62Low Tregs) (Figures 1F and 1G), a subset of
Tregs that is enriched in CD25Low and CD25Neg Tregs (Fig-
ure S1G) as well as in activated Tregs (Figure S1H) (Fontenot
et al., 2005). Accordingly, Tregs in Atg5/ DC mice were en-
riched in ICOS and CD103 effector markers (Figure 1H). In addi-
tion, Ly-6C surface expression was significantly lower in Tregs22 Cell Reports 28, 21–29, July 2, 2019from Atg5/ DC mice, compared to control mice (Figure 1I),
its downregulation being a hallmark of TCR-signaling events
(Delpoux et al., 2014). These changes in frequency and pheno-
type were restricted to Tregs, since the frequencies of memory
and naive CD4+ Foxp3Neg cells were unchanged in the SLOs of
Atg5/ DC mice (Figure S1I). Finally, we could replicate this
phenotype in Atg14/ DC mice, which lack Atg14, another
autophagy-essential gene in their DCs. Indeed, Atg14/ DC
mice display a higher frequency of Tregs in their SLOs (Fig-
ure S2A) and are enriched in CD25Low and CD25Neg subsets (Fig-
ure S2B), as well as in their effector Treg subset (Figure S2C). We
therefore concluded thatmice lacking autophagy in their DCs are
enriched in activated and effector Tregs in their SLOs, compared
to their littermate controls.
Autophagy in DCs Regulates Treg Function and Stability
To investigate the relevance of these phenotypic changes, we
assessed the function of Tregs from Atg5/ DC and Atg5+/+
DC mice by in vitro suppression assay. Surprisingly, we found
that Tregs from Atg5/ DC mice, although enriched in effector
markers, had a reduced suppressive function (Figure 2A). How-
ever, several studies have narrowed down the population of un-
stable Tregs to CD25Low/Neg subsets (Komatsu et al., 2014;
Miyao et al., 2012; Zhou et al., 2009) that are enriched in
Atg5/ DC mice. To address the hypothesis of Treg instability,
we performed RNA profiling of CD25High and CD25Low Treg sub-
sets from both Atg5+/+ DC and Atg5/ DC mice. We found dif-
ferential gene expressions in the CD25High subset and, to amuch
lower extent, in the CD25Low subset of Tregs (Figures 2B and
S2DS2G). We therefore focused our analysis on the CD25High
subset. We first determined whether CD25High Tregs from
Atg5/ DC mice share a gene expression profile with unstable
CD25Low Tregs generated in Atg5+/+ DC mice. Gene set enrich-
ment analysis (GSEA) revealed that genes upregulated in
CD25High Tregs from Atg5/ DC mice were enriched in the
CD25Low signature (Figures 2C and 2D). Since the CNS2 of the
Foxp3 gene, a CpG-rich Foxp3 intronic cis-element, has been
described to be essential for Tregs’ stability (Feng et al., 2014;
Li et al., 2014) and Foxp3 maintenance, we decided to apply
the GSEA of CNS2 knockout (KO) Tregs to our RNA sequencing
data. GSEA revealed a significant enrichment in genes from the
CNS2 KO Tregs’ signature (Figure 2E). Finally, selected GSEAs
of conventional T cell (Tconv) signatures were also enriched in
our Tregs (Figure 2F), serving as additional evidence that Tregs
from Atg5/ DC mice could be unstable and more prone to
convert to effector T cells.
We next addressed the molecular mechanism that may ac-
count for Tregs’ dysfunction and instability in Atg5/ DC
mice.We screened for potential genes involved in Tregs’ stability
through our RNA profiling analysis. We found a significantly
higher expression of the genes Hspa1a and Hspa1b encoding
for the heat shock protein 70 (HSP70) in CD25High and CD25Low
Tregs isolated from Atg5/ DC mice (Figures 2B and S2E).
Since recent publications have shown the involvement of the
STUB1-HSP70 complex in promoting FOXP3 ubiquitination
and proteasomal degradation (Chen et al., 2013), we investi-
gated the protein expression of HSP70 in Tregs upon TCR acti-
vation or exposure to inflammatory stimuli. Confirming the RNA
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Figure 1. Mice Lacking Autophagy in their DCs Have an Altered Regulatory T Cell Compartment
(A) Flow cytometry analysis of Foxp3+ CD4+ population in live CD4+ splenocytes of Atg5+/+ DC and Atg5/DCmice. Bar graph indicates the mean of frequency;
each dot represents an individual mouse. Data are a combination of six experiments with 37 mice per group.
(B) Representative fluorescence-activated cell sorting (FACS) plots showing the percentage of Ki67+ cells within CD4+ Foxp3+ splenocytes of Atg5+/+ DC and
Atg5/ mice.
(C) Bar graph indicates the mean of frequency of Ki67+. Data are a combination of three experiments with 3 mice per group.
(D) Representative FACS plot showing the gating strategy of the three subsets of Foxp3+ CD4+ cells according to CD25 expression (negative, low, and high).
(E) Bar graphs indicate themean of frequency of the three subsets of cells inAtg5+/+ DC andAtg5/DCmice. Data are a combination of six experimentswith 37
mice per group.
(F) Representative FACS plots showing the frequency of effector Tregs (CD44High CD62LLow) and central Tregs (CD62LHigh and CD44Low) in CD4+ Foxp3+ cells
from Atg5+/+ DC and Atg5/ DC mice.
(G) Bar graphs represent the mean of frequency of the two Treg subsets. Data are from four experiments with 3 mice per group.
(H and I) Flow cytometry analysis of the expression of (H) ICOS, CD103, and (I) Ly6c+ in CD4+ Foxp3+ cells. Bar graphs indicate the mean of frequency of
each marker in Atg5+/+ DC and Atg5/ DC mice. Data are from three individual experiments with 3 mice per group. *p < 0.05; **p < 0.01; ***p < 0.001 (Mann-
Whitney test).
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Figure 2. Autophagy in DCs Regulates Treg Function and Stability
(A) Left: representative FACS plots of an in vitro suppression assay using Tregs isolated from Atg5+/+ DC or Atg5/DCmice and co-cultured with cell trace violet
(CTV) labeled CD4+ CD45.1+ responder T cells (Tresps). Proliferation of Tresps was assessed by the percentage of CTV low population. Right: percentage of
inhibition of different ratios (Treg:Tresp) at day 5. The 100% proliferation is set to the 1:0 ratio of Tresp:Treg. Combined data are from two independent ex-
periments with 46 replicates per group.
(B) Volcano plot comparing differential gene expression in CD25High Tregs isolated from secondary lymphoid organs ofAtg5+/+ DC andAtg5/DCmice. Data are
combined from three individual replicates with 34 mice per replicate.
(C) Volcano plot comparing differential gene expression in CD25High and CD25Low Tregs isolated from secondary lymphoid organs of Atg5+/+ DC mice. Data are
combined from three individual replicates with 34 mice per replicate.
(D) Gene set enrichment analysis (GSEA) of Atg5-dependent CD25High Treg signature (obtained from RNA-seq data as in B) showing genes induced in CD25High
Tregs from Atg5+/+ DC mice (left) or from Atg5/ DC mice (right). FDR, false discovery rate; NES, normalized enrichment score.
(E and F) GSEA of genes upregulated in CNS2 KO versus WT Tregs (GSE 57272) (E) or Tconv versus Treg (GSE 14415) signatures (F) showing genes induced in
CD25High Tregs isolated from Atg5/ DC mice and Atg5+/+ DC mice.
(G) Western blot analysis of HSP70 expression from CD25High Tregs isolated from Atg5+/+ and Atg5/ DC mice. Tregs were activated with CD3/CD28
antibodies ± LPS for 24 h. One representative immunoblot is shown. Bar graphs indicate the relative density (mean ± SEM) of HSP70 expression related to
b-actin. Data are from three independent experiments. *p < 0.05; ***p < 0.001 (Mann-Whitney test).
(H) Tregs from Atg5/DC mice or Atg5+/+ mice were labeled with CTV and adoptively transferred to CD45.1/OT-II host mice. Left: representative FACS plots
showing the expression of Foxp3 at day 14 post transfer. Cells were gated on live CD4+ CD45.2+ CTVLow. Right: bar graphs indicate the mean frequency of
Foxp3NEG cells among CD4+ CD45.2+ cells. Data are a combination of three independent experiments.
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sequencing data, western blot analysis revealed a significantly
higher expression of HSP70 in Tregs isolated from Atg5/ DC
mice upon TCR stimulation (CD3/CD28) or inflammatory stimuli
(lipopolysaccharide [LPS]) (Figure 2G), while the level of HSP70
remained very low in the steady state (data not shown). We
therefore concluded that Tregs from Atg5/ DC mice have a
higher expression of HSP70 upon activation that might result in
enhanced FOXP3 degradation in the context of proliferation,
TCR activation (Gabrysova´ et al., 2011), or inflammation.
Accordingly, Tregs from Atg5/ DC mice lose significantly
more FOXP3 expression after 2 weeks of transfer to CD45.1/
OT-II host mice (Figure 2H).
Autophagy Deficiency in DCs Alters the Expression of
ICOS-L That Is Crucial for DC-Treg Interactions
We hypothesized that the functional and phenotypic alterations
of the Treg compartment in Atg5/ DC was secondary to
changes in DC-Treg interactions. Indeed, immature DCs have
been shown to form prolonged interactions with Tregs com-
pared to Tconvs, an interaction that results in their increased
sensitivity to limiting amounts of antigens (Sarris et al., 2008).
In parallel, in the steady state, in vivo, Tregs were shown to clus-
ter with migratory DCs in the lymph node (LN) paracortex (Liu
et al., 2015). Interestingly, this clustering is dependent on TCR
expression on the Tregs. Live cell imaging analysis revealed
that Atg5/ DCs form less-stable conjugates with wild-type
Tregs compared to Atg5+/+ DCs (Figure 3A, left). Indeed, the
mean duration of contact between Tregs and Atg5/ DCs was
significantly reduced compared to Atg5+/+ DCs, while no differ-
ence was observed for the population of conventional CD4+
T cells (Figure 3A, right). This phenotype could be related to
the regulation by the autophagy pathway of either MHC class II
expression or a co-stimulatory molecule involved in DC-Treg
contact. Indeed, autophagy has been shown to contribute to
the pool of MHC class II peptides by delivering intracellular pro-
teins to the MHC class II compartment (Schmid et al., 2007). In
parallel, the regulation of the expression of co-stimulatory mole-
cules by autophagy has already been described in the context of
inflammation, upon graft-versus-host disease (Hubbard-Lucey
et al., 2014). We did not find a difference in the expression
level of MHC class II molecules in Atg5/ DCs; therefore, we
analyzed in the steady state the expression of multiple co-stim-
ulatory ligands and adhesion molecules that were described to
play a role in DC-Treg interactions. We found that ICOS-L was
significantly decreased at the surface of both Atg5/ DCs and
Atg14/ DCs (Figures 3B and S3B). Interestingly, live cell
imaging analysis confirmed that ICOS-L blocking on WT DCs
significantly reduced the stability of their interaction with Tregs
(Figure S3A). The central contribution of the ICOS-L pathway in
Treg function and homeostasis has already been well estab-
lished for populations of both natural Tregs and induced Tregs
(iTregs) (Akbari et al., 2002). ICOS/ and ICOS-L/ animals
have a defect in the pool size of Tregs (Burmeister et al., 2008),
and blocking experiments have shown that the pathway contrib-
utes to the survival and function of effector Tregs (Raynor et al.,
2015; Smigiel et al., 2014). However, while ICOS-L expression in
plasmacytoid DCs was shown to contribute to Treg expansion
and homeostasis (Conrad et al., 2012; Faget et al., 2012; Itoet al., 2007), studies on the selective role of ICOS-L in conven-
tional DCs (Teichmann et al., 2015) and its impact on Tregs are
limited (Smigiel et al., 2014). Since ICOS-L is cleaved by
ADAM10 metalloproteinase, we wondered if ICOS-L downregu-
lation in Atg5/ DCs was related to ADAM10 accumulation. The
surface expression of ADAM10 was significantly increased in
Atg5/ DCs (Figure 3C), confirming, as recently reported in
endothelial cells, that ADAM10 is a substrate of autophagosomal
degradation (Maurer et al., 2015). Accordingly, the treatment of
DCs with ADAM10 inhibitors significantly increased ICOS-L sur-
face expression in Atg5/ DCs (Figure 3D). Because ICOS-L
was also crucial in the priming of antigen-induced Tregs (Akbari
et al., 2002), we confirmed in vitro that Atg5/ immature DCs
prime significantly less-iTregs in both a polyclonal set up and
an epitope restrictedmanner (Figure 3E). These results extended
our phenotype to the population of iTregs.
In Mice with Autophagy-Deficient DCs, Tregs Convert to
Pathogenic Th17 and Exacerbate the Severity of
Antigen-Induced Arthritis
Because the stability of Tregs is crucial during inflammation and
autoimmunity, we wanted to assess the functional relevance of
our phenotype in vivo in an inflammatory setting.We used the an-
tigen-induced arthritis (AIA) model, a Th1/Th17 model of mono-
arthritis. We found no difference in joint swelling in the acute
phase of arthritis (days 13), a stage that reflects the activation
of the innate immune response (Figure S4A). This correlates with
no differences in the expression of pro-inflammatory cytokines in
the inflamed joints of Atg5/ DC mice, compared to their litter-
mate controls (Figure S4B).
However, at a later time point (day 7), the severity of arthritis
was significantly increased in Atg5/ DC mice, as assessed by
histological scoring, showing enhanced synovial inflammation
and increased cartilage and bone erosions (Figures 4A and
4B). In agreement with this phenotype, the Th1/Th17 response
in Atg5/ DC mice was significantly higher (Figures 4C and
S4C), while no differences in specific antibody titers were de-
tected (Figure S4D). In addition, CD4+ T cells from draining
LNs showed an increased proliferation in response to in vitro an-
tigen re-stimulation (Figure S4E). This enhanced Th17 response
could not be explained by an increase in cytokines responsible
for Th17 priming (IL-1b, IL-23, or IL-6) (Figure S4B). However,
analysis of Tregs during AIA revealed a decrease in Foxp3
expression in Atg5/ DC mice, compared to their littermate
controls, a phenotype that was not present in the steady state
(Figure 4D). We therefore reasoned that Tregs in Atg5/ DC
mice were unstable upon AIA and more prone to convert to
Th17 cells, a possible mechanism leading to the increased
severity of arthritis. To address this hypothesis, we used Tregs
isolated from Foxp3-RFP/RORgt-GFP double-reporter mice.
Since retinoic acid-related orphan receptor-gt (RORgt) is a
specific transcription factor for Th17 cell commitment, the
conversion of Treg (RFP+GFP-) to Th17 (RFP+GFP-) cells could
be easily tracked in vivo post transfer. When Tregs from
Foxp3-RFP/RORgt-GFP mice were adoptively transferred
2 weeks prior to the induction of arthritis (Figures 4E and
4F), we only observed their conversion to Th17 cells in the in-
flamed knee of Atg5/ DC mice (RFP- GFP+), while in Atg5+/+Cell Reports 28, 21–29, July 2, 2019 25
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Figure 3. Autophagy Deficiency in DCs Alters DC-Treg Interactions and Reduces the Expression of ICOS-L
(A) Left: representative example of DC-T cell interaction: snapshots of live cell imaging data at indicated time points following a T cell (red dot) interactingwith a DC
(blue dot). Right: total interactions observed between CD4+ Foxp3NEG T cells or CD4+ Foxp3POS Tregs with immature Atg5+/+ or Atg5/ bone marrow derived
dendritic cells (BMDCs). All T cells in the field of view were counted if they had contacted a DC for longer than 150 s. Data are from a combination of three
individual experiments. Bar represents mean. *p < 0.05 (Mann-Whitney test).
(B andC) Representative histogram and flow cytometry analysis showingmean fluorescence intensity (MFI) of ICOS-L expression (B) and ADAM10 expression (C)
in Atg5+/+ (blue) or Atg5/ (red) BMDC. Combination of 34 independent experiments with 13 technical replicates per experiment. Data shown represent
mean ± SEM; *p < 0.05 (Mann-Whitney test).
(D) Flow cytometry analysis of ICOS-L expression fromAtg5+/+ or Atg5/BMDC treatedwith two ADAM10 inhibitors (GW280264X [GW] or GI254023X [GI]). Data
shown represent the relative fold change of the ICOS-LMFI expression from Atg5+/+ DC untreated cells. Combination of three independent experiments with 34
technical replicates per experiment.
(E) Bar graphs showing CD4+ Foxp3+ expression from an in vitro induced Treg assay from OT-II naive sorted T cells (left) or CD4 polyclonal naive sorted T cells
(right) co-cultured with ovalbumine (OVA) pulsed or control Atg5+/+ or Atg5/ BMDCs. Combined data from 34 independent experiments with 24 technical
replicates per group. Data shown represent mean ± SEM; *p < 0.05 (Mann-Whitney test).DCmice, expression of Foxp3 was sustained as RFP+GFP- cells
(Figure 4G).
Although we cannot rule out other additional mechanisms
implicated in the exacerbation of arthritis, we have shown that
Tregs convert to Th17 upon AIA in Atg5/ DC mice. Other
studies have implicated autophagy in Tregs’ function. In partic-
ular, Tregs were shown to inhibit the autophagic machinery in
DCs in order to restrain their function (Alissafi et al., 2017). In par-
allel, the intrinsic conditional deletion of autophagy in Tregs was26 Cell Reports 28, 21–29, July 2, 2019shown to impair their function and integrity (Kabat et al., 2016;
Wei et al., 2016).
Our data identify a mechanism where the autophagy pathway
in DCs contributes to Tregs’ stability and homeostasis in both
steady state and inflammation. In the absence of autophagy in
DCs, ICOS-L is downregulated as a consequence of ADAM10
accumulation, the metalloproteinase responsible for its cleav-
age. Accordingly, DC-Treg interactions are modified, resulting
in Tregs’ dysfunction and instability. Since genetic association
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Figure 4. In Mice Lacking Autophagy in Their DCs, Tregs Convert to Pathogenic Th17 and Exacerbate Antigen-Induced Arthritis
(A) Representative histological sections of arthritic knee joints at d7 post-arthritis onset in Atg5+/+ DC or Atg5/ DC mice. Top: H&E staining. Arrows show
synovial hyperplasia. Bottom: toluidine blue staining for articular cartilage analysis. Scale bars are depicted in the lower left of each histological section (0.2 mm)
(B) Combined histological scoring of two antigen-induced arthritis (AIA) experiments (n = 610 mice per group).
(C) IL-17 production from inguinal lymph node (LN) cell suspensions. T cells were stimulated with PBS, methylated BSA (mBSA), or CD3/CD28. Data are
combined from 2 to 3 experiments with 8 to 10 mice per group.
(D) Representative FACS plots showing Foxp3+ expression within splenic CD4+ Foxp3+ cells during AIA at d5 and d7 post-arthritis induction (left). Bar graph
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(F) Outline of immunization time points in the AIA model with RFP+-Foxp3+ adoptive transfer.
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experiments, with 34 mice per group. Data shown represent mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001 (Mann-Whitney test).
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studies have linked autophagy gene polymorphisms to autoim-
mune and inflammatory disorders, we propose that autophagy
dysfunction in DCs could result in Treg instability and precipitate
autoimmune disorders.
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LEAF Purified Rat IgG2a, k Isotype Ctrl BioLegend Cat# 400533
Rat Anti-Mouse Adam-10 purified (139712) R and D Systems Cat#MAB946; RRID:AB_2222927
Anti-HSPA1A Sigma-Aldrich Cat#SAB2700846
Goat Anti-Rabbit IgG (H+L)-HRP conjugate Bio-Rad Cat#1706515 RRID:AB_11125142
Goat Anti-Mouse IgG (H + L)-HRP Bio-Rad Cat#1706516 RRID:AB_11125547
Chemicals, Peptides, and Recombinant Proteins
LIVE/DEAD Fixable aqua stain kit Invitrogen – ThermoFisher Scientific Cat#L34957
LIVE/DEAD Fixable NEAR-IR stain kit Invitrogen – ThermoFisher Scientific Cat#L10119
Recombinant mouse GM-CSF PeproTech Cat#315-03
Cell trace CFSE cell proliferation kit Invitrogen – ThermoFisher Scientific Cat#C34554
Cell trace violet cell proliferation kit Invitrogen – ThermoFisher Scientific Cat#C34557
Recombinant human IL-2 Peprotech Cat#200-02
ADAM inhibitor GI254023X Sigma-Aldrich Cat#SML0789
ADAM inhibitor GW280264X Aobious Cat#AOB3632
Collagenase D Roche-Sigma-Aldrich Cat#11088858001
DNase Sigma-Aldrich Cat#1010415900
HEPES buffer GIBCO - ThermoFisher Scientific Cat#15630056
Recombinant human TFG-b eBioscience - ThermoFisher Scientific Cat#14-8348
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REAGENT or RESOURCE SOURCE IDENTIFIER
OVA specific peptide (OVA 323-339) InvivoGen Cat#Vac-isq
Lipopolysaccharides from Escherichia coli O55:B5 Sigma-Aldrich Cat#L2880
Methylated bovine serum albumin Sigma-Aldrich Cat#A1009
Complete Freund’s adjuvant Chondrex - Amsbio Cat#7001
Incomplete Freund’s adjuvant Chondrex - Amsbio Cat#7002
Critical Commercial Assays
RNeasy Mini kit QIAGEN Cat#74104
IL-17 ELISA ebioscience –ThermoFisher Scientific Cat#88-7371-88
IFNɣ ELISA ebioscience –ThermoFisher Scientific Cat# 88-7314-88
EasySep Mouse CD4+ T Cell Isolation Kit Stem Cell Technologies Cat#19752
CD11c MicroBeads UltraPure, mouse Miltenyi Biotec Cat#130-108-338
Deposited Data
RNA sequencing data This study GEO: GSE98961
Experimental Models: Organisms/Strains
Atg5flox/flox Pr Noburu Mizushima (Tokyo,Japan) MTA
CD11c-Cre Tg The Jackson Laboratory Cat#007567
Foxp3RFPRORgtGFP Dr Mathias Lochner, Hannover Medical
school
C57BL/6 CD45.1 Charles River Laboratories Cat#494
C57BL/6 OT II The Jackson Laboratory Cat#004194
Atg14flox/flox Pr Shizuo Akira (Osaka,Japan) MTA 17-059
Oligonucleotides
Primer: IL-6 forward: GCTACCAAACTGGATATAA
TCAGGA
This paper N/A
Primer: IL-6 reverse: GCTACCAAACTGGATAT
AATCAGGA
This paper N/A
Primer: IL-1b forward AGTTGACGGACCCCAAAAG This paper N/A
Primer: IL-1b reverse AGCTGGATGCTCTCATCAGG This paper N/A
Primer: IL-23 forward TCCCTACTAGGACTCA
GCCAAC
This paper N/A
Primer:IL-23 reverse AGAACTCAGGCTGGGCATC This paper N/A
Primer: GAPDH forward ACGGCCGCATCTTC
TTGTGCA
This paper N/A
Primer: GAPDH reverse AATGGCAGCCCT
GGTGACCA
This paper N/A
Software and Algorithms
Flow Jo Version 10. software (Treestar) Treestar Inc N/A
Kalusa analysis software (version1.3) Beckman Coulter N/A
Prism 7 Graphpad Inc
ImageJ National Institute of Health, available
online
N/ALEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Monique
Gannage´: Monique.ghannage@chuv.ch.Cell Reports 28, 21–29.e1–e6, July 2, 2019 e2
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
Mice strains used in this study are: CD45.1(Charles River, France), C57BL/6 (Janvier), Atg5flox/flox(Hara et al., 2006) (Pr Mizushima,
Tokyo, Japan), CD11c-Cre Tg (Jackson Laboratory), Atg14flox/flox (Pr Akira, Osaka Japan), OT-II (Charles River Laboratory), Foxp3RFP
RORgtGFP(Mathias Lochner, Hannover Medical School). Atg5/ DC mice (Atg5flox/flox _CD11-Cre+/) and Atg5 +/+ DC (Atg5flox/flox _
CD11-Cre/) mice were obtained by crossing Atg5flox/flox mice to CD11-Cre+/mice. Animals were crossed, bred and housed under
specific-pathogen-free conditions in the animal facility of the faculty of Medicine, University of Geneva, Switzerland. Male and female
mice ranging from 8-14 weeks of age were used in experiments. Animals were aged and sex matched and assigned to experimental
groups, using littermate controls. All animal protocols were approved by the cantonal veterinary office of the canton of Geneva,
Switzerland (authorization number GE/103/18 and GE/38/14 and FRM1005-Medicine CMU).
Primary cells
Bone marrow derived dendritic cells (BMDCs)
Bone marrow cells were isolated from tibias and femurs from Atg5+/+ DC and Atg5/DC mice. Cells were expanded using X63 cell
supernatant as a source of GM-CSF or recombinant GM-CSF (20ng/ml) in culture medium. GM-CSF supplemented media was re-
placed every three days. Cells were used at Day 10 of culture. For functional assay, to ensure a pure DC population of > 90%CD11c+
MHCII+, cells were enriched by CD11c+ selection (Miltenyi).
Splenic DCs
Splenocytes fromAtg5+/+DC orAtg5/DCmice were digested using 0.2mg/ml Collagenase D (Roche), 25ug/ml DNase (Sigma) and
25mM HERPES (GIBCO) for 30 min at 37C. After red blood cell lysis, the single cell splenocytes suspension obtained underwent
FACS staining or was enriched by CD11c+ selection (Miltenyi) before FACS sorting.
METHOD DETAILS
FACS analysis
For staining, the following Abs were purchased from Biolegend BD Bioscience, or ebioscience (unless otherwise stated) as conju-
gated to FITC, PE, PE-CF 594, PE-Cy7, PerCP-Cy5.5, APC, APC-Cy7, Alexa Fluor 700, Pacific Blue: anti-CD4 (RM4-5), CD44
(IM7), CD62L (MEL-14), CD25 (PC61), CD45.1 (A20), CD45.2 (104), CD103 (2E7), CD69 (H1.2F3), ICOS (7E.17G9), CD11c (N418),
MHCII /I-Ab (AF6-120.1), Ki67 (SolA15, eBioscience), Foxp3 (FJK-16 s). ICOS L (HK-5.3), CD80 (16-10A1), CD86 (GL-1), CD40
(HM40-3), Semaphorin 4a (5E3), CD308 (3DS304M). For ADAM10 expression, cells were first stained with Anti-rat ADAM10 (purified
Rat-monoclonal, clone 139712, R&D systems), followed by an Anti-Rat PE conjugated secondary antibody (Jackson). For dead cell
exclusion, LIVE/DEAD fixable Aqua or Near-IR kit (Invitrogen) was used. Cells were acquired on a Gallios flow cytometer (Beckman
Coulter), or on an LSR Fortessa (BD Bioscience). All flow cytometry analysis were performed using Flow Jo Version 10. software
(Treestar) or Kalusa analysis software (version1.3).
FACS sorting
For Treg isolation, CD4+ T cell populations, from LN and spleens were selected by a CD4 negative selection kit (Stem Cell Technol-
ogies). After the CD4+ enrichment, cells were labeled with the specific Abs, as follow: for isolation of CD25High/Low T reg populations,
CD4+ CD62LHigh (CD44Low) CD25High or CD4+ CD62LHigh (CD44 Low) CD25 Low or CD4+ CD62LHigh (CD44Low) total CD25+ were iso-
lated. Post-sort analysis of Treg purity was assessed by FACS by Foxp3 staining (purity between 95 and 97%).
For Treg adoptive transfer experiments, CD4+ RFP+ cells were isolated from Foxp3RFPRORgtGFP mice.
For CD4+ Naive T cells isolation, CD4+ T cell populations from LN and spleens were selected by a CD4 negative selection kit (Stem
Cell Technologies). CD4+ CD62LHigh CD44 Low CD25 Neg were FACS sorted.
For Treg adoptive transfer to CD45.1 OT-II mice, Tregs (CD4+ CD62L+ CD25+) were FACS sorted from Atg5+/+DC or Atg5/DC
mice and stained with cell trace violet (Invitrogen).
For DC isolation, Splenic DCs were FACS sorted as CD11cHigh MHC class II High .
All cells were sorted on a Beckman Coulter MoFlo Astrios or a Biorad S3 sorter.
Induced Treg assay
BMDCs from Atg5+/+ or Atg5/ mice were obtained as previous described. For polyclonal Tregs induction: Naive T cells from
CD45.1 cells were isolated by FACS sorting. 1x105 T cells were co cultured with 1x105 Atg5+/+ or Atg5/ BMDC in the presence
of 500 U/ml IL-2 and 20ng/ml TFG-b. Cytokines were replaced at day 3 of culture and cells isolated on day 5 for analysis CD4+
Foxp3+ expression by flow cytometry. For OVA specific Tregs induction: Naive T cells were isolated from OT-II TCR mice and co-
cultured with BMDC which had undergone pulsing with 0.1ug/ml OVA specific peptide (OVA peptide 323-339, InvivoGen) for 2h
at 37C. Cells were then washed before the co-culture.e3 Cell Reports 28, 21–29.e1–e6, July 2, 2019
Treg functional assay
To determine the suppression capacity of Tregs in vitro, FACS sorted T regs from Atg5+/+ DC or Atg5/ DC mice were co-cultured
with FACs sorted Naive CD45.1 cells which were labeled with cell trace violet (Invitrogen), in the presence of FACS sorted splenic
DCs. Treg: T naive cells were cultured in RPMI supplemented with 10% FCS, 1% p/s and 2x105 M b-2 mercapto-ethanol at varying
ratios, with 0.2 mg/ml of anti-CD3 (Biolegend). After 5 days, proliferation of effector cells was assessed by the loss of cell trace violet
expression on CD4+ CD45.1+ by flow cytometry.
ADAM inhibition for ICOSL regulation
BMDC fromAtg5+/+ orAtg5/micewere obtained as previous described. At day 10 of culture, 0.5x106 cells were seeded in a 12well
plate in completemedium supplemented with 20ng/ml GM-CSF. Cells were then treated for 24hwith 3mMADAM inhibitor GI254023X
(Sigma) or GW280264X (Aobious). The expression of ICOS-L was then assessed by flow cytometry.
Antigen Induced Arthritis (AIA) model
Micewere immunized subcutaneously at the base of the tail with 100ugmethylated bovine serum albumin (mBSA) (Sigma) emulsified
in complete Freund’s adjuvant (CFA) (Chondrex). On day 7, mice underwent a boost injection of 100ug mBSA emulsified with incom-
plete Freund’s adjuvant (Chondrex). Arthritis was induced on day 21 by intra-articular injection of 100ugmBSA into the left knee joint,
PBSwas injected into the right knee joint. Joint swelling was evaluated bymeasuring 99 mTechnetium (Tc) uptake, on day 1 and day 3
post injection. Briefly, 10uCi 99 m Tc, mice was injected subcutaneously in the neck, and after 30 min knee joint were placed on a
gamma counter. The ratio of 99 m Tc up take in the inflamed joint was calculated as compared to the PBS control joint. Mice were
sacrificed at day 28 unless otherwise stated.
Histological analysis of AIA
At day 28 post AIA induction, mice were sacrificed and knee joints were fixed in 10%buffered formalin, decalcified in 10%EDTA, and
embedded in paraffin. Sections were stained with hematoxilin and eosin or toluidine blue and graded by one pathologist (CAS) in a
blinded manner. The severity of the synovial inflammation including synovial hyperlasia and the % of neutrophil cell infiltration, as
well as the degree of cartilage and bone erosion were evaluated utilizing a scoring system(Camps et al., 2005) ranging from 0 to 4
(0 = normal, 1 = minimal, 2 = moderate, 3 = severe, 4 = very severe).
T cell proliferation assay post-AIA
To assess T cell proliferation, lymph node cell suspensions taken at day 7 post arthritis induction were labeled with carboxy-fluores-
cein diacetate succin-imidyl ester (CFSE) and treated ex vivowith 10mg/ml mBSA or 2.5mg/ml CD3/CD28 (Biolegend), and cultured in
RPMI supplemented with 10% FCS, 1% p/s and 2x105 M b-2 mercapto-ethanol.. After 72h, cells were harvested and proliferation
assessed by loss of CFSE staining by flow cytometry.
ELISA Assay
For detection of cytokines production from T cells during AIA, single cell suspensions were prepared from lymph nodes taken at day 7
post arthritis induction and treated ex vivo with 10mg/ml mBSA or 2.5mg/ml CD3/CD28 (Biolegend), and cultured in RPMI supple-
mented with 10% FCS, 1% p/s and 2x105 M b-2 mercapto-ethanol. After 72h supernatants were tested for IL-17 and IFNɣ cytokine
production by ELISA according to manufacturer’s specifications (e.Bioscience).
For anti-mBSA IgG antibody levels: To assess anti-mBSA specific antibody production during AIA, serum was collected from
arthritic mice at day 7 post arthritis induction. mBSA (Sigma), at 10ug/ml was coated on 96 well plates (Nunc) overnight at 4C in
PBS. After multiple washes with 0.05%PBS Tween, serumwas serially diluted and incubated with HRP-conjugated antibody for mu-
rine total IgG, IgG2A or IgG1. The plates were then washed and incubated with 3,30,5,50-Tetramethylbenzidine (TMB) substrate. Anti-
body titers were determined by taking the last positive OD readout above the background. The background was determined by the
OD values from the serum of mouse injected with CFA only.
Treg adoptive transfer upon AIA
To determine the conversion of Foxp3-RFPPOS to Rorcɣt-GFPPOS during AIA, RFPposGFPneg cells were isolated by FACS and injected
IV at day 6 post immunisation. Knee joints were isolated at day 28 (21 days post transfer), and single cell suspensions of knee joints
were achieved after knee digestion (0.2mg/ml collagenase A) and Percoll density centrifugation. Foxp3 RFPpos and Rorcɣt GFPpos
cells were identified by flow cytometry. Background GFP+ or RFP+ was determined from non-injected control mice (3 mice per
phenotype). For the analysis of Tregs in the knee, all GFP+ values < 1% and Foxp3 RFP+ values < 0.6% were considered as back-
ground. Mice having a minimum of 450 CD4+ CD45+ cells in the live gate were included in FACS analysis. According to rare event
analysis the precision of our data was lower or equal to 20% (as calculated by n1/2 were n is the total numbers of cells, in the live
gate). For the analysis of splenic Tregs, all GFP+ values < 0.3% and Foxp3 RFP+ values < 0.07% were considered as background
Quantitative RT-PCR (qPCR)
At day 4 post arthritis induction, knee joints from mBSA treated or PBS control were snap frozen. Total RNA was extracted using
TRIzol (Invitrogen) and RNeasy mini columns with DNase digestion, according to manufacturer’s instructions (QIAGEN). Reverse
transcription was preformed using Superscript II (Invitrogen). The RT product was diluted and used as a template for quantitative
PCR (qPCR) on aCFXConnect real-time detection system (Biorad) using kappa SYBRGreen (KappaBiosystems). The following spe-
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IL-6 forward 50 GCTACCAAACTGGATATAATCAGGA 30
IL-6 reverse 50CCAGGTAGCTATGGTACTCCAGAA 30.
IL-1b forward 50AGTTGACGGACCCCAAAAG 30
IL-1b reverse 50 AGCTGGATGCTCTCATCAGG 30
IL-23 forward 50 TCCCTACTAGGACTCAGCCAAC30
IL-23 reverse 50 AGAACTCAGGCTGGGCATC 30.
GAPDH forward 50 ACGGCCGCATCTTCTTGTGCA30
GAPDH reverse 50 AATGGCAGCCCTGGTGACCA 30
Relative fold change of gene expression was determined by analysis of the cycle threshold values (CT), and normalized to the
expression of the GAPDH (delta CT).
The delta delta CT was than calculated taking the delta CT mean of PBS treated control knee joint in Atg5+/+ DC mice as a refer-
ence. The fold change of expression in the inflamed knee was calculated as (2^ -DDCT).
Treg adoptive transfer to CD45.1 OT-II mice
For T reg transfer to CD45.1 OT-II mice, Tregs (CD4+ CD62L+ CD25+) were FACS sorted from Atg5+/+DC or Atg5/DC mice and
stained with a proliferation dye. 200 000 T regs were then injected (IV) into a CD45.1 OT-II mouse. After 14 days post transfer, sple-
nocytes were isolated and the CD45.2 proliferating Treg population was determined by flow cytometry to assess Foxp3 expression.
Time lapse Video Microscopy
BMDC generated from Atg5+/+ or Atg5/mice (53 104) were co-cultured with CD4+ Foxp3RFP positive or Foxp3RFP negative T cells
sorted from the Foxp3RFPRORgtGFP double reporter mice (1 3 105) were observed in a 8 well m-slide (Ibidi) on a Zeiss observer.Z1
microscope with a 37C heated stage. After 10 min, DIC images were obtained for 20min with 10 s intervals. Images were then
analyzed using ImageJ software, all DC/T cell interactions above 150 s (stochastic) were taken into account for analysis. At least
100 interactions were analyzed for each condition.
For blocking experiments, cells were incubated for 10 min at 4C with 2 ug/ml anti-CD16/32 followed by incubation of 10 ug/ml of
anti-ICOSL (Clone HK5.3) or an isotype control for 30 min at 4C. All DC/T cell interactions were taken into account for analysis.
Western blot
Lysates were prepared from FACS sorted Tregs (from Atg5+/+ DC and Atg5/ DC mice) treated with 1mg/ml CD3/CD28 (Bioexcel),
and 1mg/ml LPS (Sigma) for 24h. Cells were lysed in 50mMTris-HCl (pH 7.5), 1%NP-40 buffer supplemented with protease inhibitors
(Roche). Equal protein amounts from lysates were used after bicinchoninic acid assay quantification (Pierce). Protein samples were
than denatured in Laemmli buffer, separated by SDS-polyacrylamide gel electrophoresis and transferred to PVDF membranes. Im-
munoblots were blocked and primary antibody for HSP70 (Sigma) was incubated in PBS supplemented with 0.05% Tween-20 (v/v)
and 5% (w/v) non-fat dry milk overnight at 4C. HRP-conjugated Goat -anti Rabbit (Biorad) was used to detect proteins by enhanced
chemiluminescence.
RNA sequencing and data analysis
RNA was isolated from CD25High and CD25Low Treg subsets of Atg5+/+ DC or Atg5/ DCmice, using the RNeasy Mini kit according
to manufacturer’s instructions (QIAGEN). Total RNA was quantified with a Qubit (fluorimeter from Life Technologies) and RNA integ-
rity assessed with a Bioanalyzer (Agilent Technologies). The SMARTer Ultra Low RNA kit from Clontech was used for the reverse
transcription and cDNA amplification according to manufacturer’s specifications, starting with 10 ng of total RNA as input. 200 pg
of cDNA were used for library preparation using the Nextera XT kit from Illumina. Library molarity and quality was assessed with
the Qubit and Tapestation using a DNAHigh sensitivity chip (Agilent Technologies). Pools of 6 libraries were loaded at 13 pM for clus-
tering on a Single-read Illumina Flow cell. Reads of 50 bases were generated using the TruSeq SBS HS v3 chemistry on an Illumina
HiSeq 2500 sequencer. FastQ reads were mapped to the ENSEMBL reference genome (GRCh38.80) using STAR version 2.4.0j(Do-
bin et al., 2013) with standard settings, except that any reads mapping to more than one location in the genome (ambiguous reads)
were discarded (m= 1). A unique genemodel was used to quantify reads per gene. Briefly, themodel considers all annotated exons of
all annotated protein coding isoforms of a gene to create a unique gene where the genomic region of all exons are considered coming
from the same RNAmolecule and merged together. All reads overlapping the exons of each unique gene model were reported using
featureCounts version 1.4.6-p1(Quinlan and Hall, 2010). Gene expressions were reported as raw counts and in parallel normalized in
RPKM in order to filter out genes with low expression value (1 RPKM) before calling for differentially expressed genes. Library size
normalizations and differential gene expression calculations were performed using the package edgeR(Robinson et al., 2010) de-
signed for the R software. Only genes having a significant fold-change (Benjamini-Hochberg corrected p value < 0.01) were consid-
ered for the rest of the RNA sequencing analysis.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including the exact value of n, the dispersion, the precision of measures (mean+/ sem) and the statistical
significance are reported in the figures and figure legends. In all experiments, Mann Whitney unpaired non-parametric t test wase5 Cell Reports 28, 21–29.e1–e6, July 2, 2019
used (unless otherwise stated in the legend) using PRISM software (Version 6.01; GraphPad software). Data are presented as the
mean ± sem. The statistical significance level was set at p values, and depicted as following: *p < 0.05, **p < 0.01 and ***p < 0.00.
DATA AND CODE AVAILABILITY
Software All software are freely or commercially available and listed in the STAR METHODS
Data Resources
Data used in this manuscript are available upon request. The raw and processed RNA-seq data have been deposited to the Gene
Expression Omnibus (GEO) accession number under GEO: GSE98961.Cell Reports 28, 21–29.e1–e6, July 2, 2019 e6
